163 related articles for article (PubMed ID: 1889421)
21. Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease.
Bradová V; Smíd F; Ulrich-Bott B; Roggendorf W; Paton BC; Harzer K
Hum Genet; 1993 Sep; 92(2):143-52. PubMed ID: 8370580
[TBL] [Abstract][Full Text] [Related]
22. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
Sandhoff K; Kolter T
Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
[TBL] [Abstract][Full Text] [Related]
23. The effect of carbohydrate removal on stability and activity of saposin B.
Hiraiwa M; Soeda S; Martin BM; Fluharty AL; Hirabayashi Y; O'Brien JS; Kishimoto Y
Arch Biochem Biophys; 1993 Jun; 303(2):326-31. PubMed ID: 8099782
[TBL] [Abstract][Full Text] [Related]
24. The precursor of sulfatide activator protein is processed to three different proteins.
Fürst W; Machleidt W; Sandhoff K
Biol Chem Hoppe Seyler; 1988 May; 369(5):317-28. PubMed ID: 3048308
[TBL] [Abstract][Full Text] [Related]
25. Thermotropic behavior of mixtures of glycosphingolipids and phosphatidylcholine: effect of monovalent cations on sulfatide and galactosylceramide.
Rintoul DA; Welti R
Biochemistry; 1989 Jan; 28(1):26-31. PubMed ID: 2539858
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of oligodendrocytes cultured from developing rat brain is enhanced by exogenous GM3 ganglioside.
Yim SH; Farrer RG; Hammer JA; Yavin E; Quarles RH
J Neurosci Res; 1994 Jun; 38(3):268-81. PubMed ID: 7523687
[TBL] [Abstract][Full Text] [Related]
27. Identity of the activator proteins for the enzymatic hydrolysis of sulfatide, ganglioside GM1, and globotriaosylceramide.
Vogel A; Fürst W; Abo-Hashish MA; Lee-Vaupel M; Conzelmann E; Sandhoff K
Arch Biochem Biophys; 1987 Dec; 259(2):627-38. PubMed ID: 3426245
[TBL] [Abstract][Full Text] [Related]
28. Recombinant GM2-activator protein stimulates in vivo degradation of GA2 in GM2 gangliosidosis AB variant fibroblasts but exhibits no detectable binding of GA2 in an in vitro assay.
Bierfreund U; Lemm T; Hoffmann A; Uhlhorn-Dierks G; Childs RA; Yuen CT; Feizi T; Sandhoff K
Neurochem Res; 1999 Feb; 24(2):295-300. PubMed ID: 9972878
[TBL] [Abstract][Full Text] [Related]
29. Occurrence of sulfatide as a major glycosphingolipid in WHHL rabbit serum lipoproteins.
Hara A; Taketomi T
J Biochem; 1987 Jul; 102(1):83-92. PubMed ID: 3667567
[TBL] [Abstract][Full Text] [Related]
30. Tissue accumulation of sulfatide and GM3 ganglioside in a patient with variant Farber disease.
Fujiwaki T; Hamanaka S; Tate S; Inagaki F; Suzuki M; Suzuki A; Mori C
Clin Chim Acta; 1995 Jan; 234(1-2):23-36. PubMed ID: 7758220
[TBL] [Abstract][Full Text] [Related]
31. The glycosphingolipid composition of the human hepatoma cell line,Hep-G2.
Spitalnik PF; Danley JM; Burger SR; Spitalnik SL
Arch Biochem Biophys; 1989 Sep; 273(2):578-91. PubMed ID: 2549875
[TBL] [Abstract][Full Text] [Related]
32. Binding of pulmonary surfactant protein A to galactosylceramide and asialo-GM2.
Kuroki Y; Gasa S; Ogasawara Y; Makita A; Akino T
Arch Biochem Biophys; 1992 Dec; 299(2):261-7. PubMed ID: 1444464
[TBL] [Abstract][Full Text] [Related]
33. Conversion of short-chain ceramides to short-chain ceramide GM3 in B16 melanoma cells.
Komori H; Ito M
FEBS Lett; 1995 Oct; 374(2):299-302. PubMed ID: 7589558
[TBL] [Abstract][Full Text] [Related]
34. Interaction of GM2 activator protein with glycosphingolipids.
Li SC; Hama Y; Li YT
Adv Exp Med Biol; 2001; 491():351-67. PubMed ID: 14533808
[TBL] [Abstract][Full Text] [Related]
35. Estrogen-induced alterations of hematoside of rat small intestinal mucosa.
Dahiya R; Brasitus TA
Biochim Biophys Acta; 1987 Apr; 918(3):230-5. PubMed ID: 3567211
[TBL] [Abstract][Full Text] [Related]
36. A unique glycosphingolipid-splitting enzyme (ceramide-glycanase from leech) cleaves the linkage between the oligosaccharide and the ceramide.
Li SC; DeGasperi R; Muldrey JE; Li YT
Biochem Biophys Res Commun; 1986 Nov; 141(1):346-52. PubMed ID: 3801005
[TBL] [Abstract][Full Text] [Related]
37. Neutral glycosphingolipids and gangliosides of bovine thyroid.
Iwamori M; Sawada K; Hara Y; Nishio M; Fujisawa T; Imura H; Nagai Y
J Biochem; 1982 Jun; 91(6):1875-87. PubMed ID: 7118850
[TBL] [Abstract][Full Text] [Related]
38. Biochemical, immunological, and structural studies on a sphingolipid activator protein (SAP-1).
Inui K; Wenger DA
Arch Biochem Biophys; 1984 Sep; 233(2):556-64. PubMed ID: 6435528
[TBL] [Abstract][Full Text] [Related]
39. Oligosaccharide behavior of complex natural glycosphingolipids in multicomponent model membranes.
Singh DM; Shan X; Davis JH; Jones DH; Grant CW
Biochemistry; 1995 Jan; 34(2):451-63. PubMed ID: 7819237
[TBL] [Abstract][Full Text] [Related]
40. Comparative monolayer investigations of surface properties of negatively charged glycosphingolipids from vertebrates (gangliosides) and invertebrates (SGL-II, lipid IV).
Beitinger H; Schifferer F; Sugita M; Araki S; Satake M; Möbius D; Rahmann H
J Biochem; 1989 Apr; 105(4):664-9. PubMed ID: 2760023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
